A comprehensive real-time PCR-based in vitro diagnostic assay designed for the quantitative detection of Hepatitis C Virus (HCV) RNA in clinical specimens, including plasma and serum. Enables accurate and sensitive quantification of HCV viral load, facilitating early diagnosis, effective clinical management, disease monitoring, antiviral treatment response assessment, and evaluation of disease progression.
Hepatitis C Virus (HCV) is an RNA virus that primarily infects liver cells (hepatocytes) and can lead to both acute and chronic liver infections. While some infections may remain asymptomatic, chronic HCV infection can result in serious complications such as liver cirrhosis, liver failure, and hepatocellular carcinoma (liver cancer).
HCV is a major global health concern and is primarily transmitted through contact with infected blood and body fluids, including unsafe injections, blood transfusion, and needle sharing. The Genplex™ HCV RT-PCR Kit provides accurate quantitative measurement of viral RNA to enable timely diagnosis and treatment monitoring.
The assay is validated for use with ThermaCyte X16 & X96 (Probgen Brand) as well as most other open RT-PCR instruments. Internal Control (IC) is included in every reaction to validate extraction efficiency and detect inhibition.
Advanced molecular diagnostic capabilities engineered for clinical excellence and research-grade precision.
Specific detection and quantification of HCV RNA using dedicated primers and fluorescently labeled probes.
Accuracy ≥100% across diverse HCV genotypes — minimizing false negatives and false positives.
Precise quantification from low to high viral load — supporting treatment response monitoring and initial diagnosis.
Four calibrated quantification standards with defined HCV RNA concentrations for accurate viral load measurement.
Validated on major RT-PCR platforms including ThermaCyte X16 & X96 (Probgen) and most open RT-PCR instruments.
Built-in IC detects inhibition and validates extraction in every reaction — preventing false-negative results.
Designed for diverse diagnostic and research use cases across the clinical spectrum.
Accurate quantification of HCV viral load for diagnosis, monitoring, and management of hepatitis C infection in clinical laboratories.
Screening of blood donations to ensure safety and prevent transfusion-transmitted HCV infections.
Monitor treatment response and assess sustained virological response (SVR) during and after antiviral therapy.
Surveillance and population studies tracking HCV prevalence, genotype distribution, and disease burden.
| Parameter | Value / Description |
|---|---|
| Target Pathogen | Hepatitis C Virus (HCV) RNA |
| Assay Type | Singleplex Quantitative RT-PCR |
| Sample Type | Plasma, Serum |
| Sensitivity | ≥ 100% |
| Specificity | ≥ 100% |
| Internal Control | Included in every reaction |
| Standards | 4 Quantification Standards (QS1–QS4) |
| Compatible Instruments | ThermaCyte X16, ThermaCyte X96, and most open RT-PCR platforms |
| Intended Use | In Vitro Diagnostic (IVD) |
| Storage | -20°C |
For in vitro diagnostic use. Contact your regional distributor or ProbGen representative to place an order.
| Product Name | Cat. No. | Pack Size |
|---|---|---|
| Genplex™ Hepatitis C Virus (HCV) RT-PCR KIT | GP1048 | 48 tests |
| Genplex™ Hepatitis C Virus (HCV) RT-PCR KIT | GP1049 | 96 tests |
Contact our scientific team for technical specifications, bulk pricing, or to request a demonstration of our diagnostics solutions.
Contact Us All Products